title: Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?
authors.forename: Rajesh
authors.initials: R
authors.lastname: Peter
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Reilly
authors.forename: Sony
authors.initials: S
authors.lastname: Anthony
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D008076:Cholesterol, HDL / Q000378:metabolism; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D003925:Diabetic Angiopathies / Q000209:etiology / Q000517:prevention & control; D058607:Fibric Acids / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors; D014280:Triglycerides / Q000378:metabolism
chemical_list: D008076:Cholesterol, HDL; D058607:Fibric Acids; D000960:Hypolipidemic Agents; D014280:Triglycerides